Evidence map›Paper›PMID 39926165›Full record

ArticleJAMIA open2025

Increased discoverability of rare disease datasets through knowledge graph integration.

Ian Braun, Emily Hartley, Daniel Olson, Nicolas Matentzoglu, Kevin Schaper, Ramona Walls, Nicole Vasilevsky

Abstract read
In one paragraph

Article in JAMIA open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ian BraunData Collaboration Center, Critical Path Institute, Tucson, AZ 85718, United States.ORCID https://orcid.org/0000-0002-2389-9288
Emily HartleyData Collaboration Center, Critical Path Institute, Tucson, AZ 85718, United States.
Daniel OlsonData Collaboration Center, Critical Path Institute, Tucson, AZ 85718, United States.
Nicolas MatentzogluIndependent Consultant, Semanticly, Athens 10563, Greece.
Kevin SchaperDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
Ramona WallsData Collaboration Center, Critical Path Institute, Tucson, AZ 85718, United States.
Nicole VasilevskyData Collaboration Center, Critical Path Institute, Tucson, AZ 85718, United States.

Funding

FDA HHS U18 FD005320
6 · The paper itself

Abstract

Objectives: Demonstrate a methodology for improving discoverability of rare disease datasets by enriching source data with biological associations. Materials and Methods: We developed an extension of the Biolink semantic model to incorporate patient data and generated a knowledge graph (KG) comprising patient data and associations between biological entities in an existing KG, leveraging existing mappings and mapping standards. Results: The enriched model of patient data can support a search application that is aware of biological associations and provides a semantic search interface to discover and summarize patient datasets within the broader biological context. Discussion and Conclusion: Our methodology enriches datasets with a wealth of additional biological knowledge, improving discoverability. Using condition concepts, we illustrate techniques that could be applied to other entities within source data such as measurements and observations. This work provides a foundational framework for how source data can be modeled to improve accuracy of upstream language models for natural language querying.

Indexed as

knowledge graphontologyrare disease

Identifiers

PMID39926165
PMCPMC11806703

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.